Resources Contact Us Home
Binding peptides for carcinoembryonic antigen (CEA)

Image Number 5 for United States Patent #7438890.

The present invention provides binding moieties for CEA, which have a variety of uses wherever detecting, isolating or localizing CEA, and particularly CEA as opposed to cross-reactive antigens such as NCA, is advantageous. Particularly disclosed are synthetic, isolated polypeptides capable of binding CEA, which is overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon. Such polypeptides and disclosed derivatives are useful, e.g., as imaging agents for CEA-expressing tumors.

  Recently Added Patents
Method and apparatus for user selection of advertising combinations
Multiple RF band operation in mobile devices
Isoselective polymerization of epoxides
Data distribution apparatus, data distribution method, and distribution control program
Cryptographic key split combiner
Policy based cryptographic application programming interface in secure memory
Method and structure for forming ETSOI capacitors, diodes, resistors and back gate contacts
  Randomly Featured Patents
Shapable resin compositions
Method and product for cleaning cooking grills
Blender with safety device
Cationic charge modified microporous membrane
Control system for automatic resumption of speed control after gear change
Systems and methods for high-throughput microfluidic sample analysis
Meter readout with DC motor impulse generator
Superconducting latch driver circuit generating sufficient output voltage and pulse-width
Method for making Group III nitride devices and devices produced thereby
Polycosanols from Ericerus pela wax